NEW YORK (GenomeWeb News) – Olink Bioscience and Abnova have agreed to a co-development and co-marketing partnership for protein assays, Olink said today.

Under the agreement, the companies will jointly market hundreds of target-specific assays, and will combine Abnova's collection of antibodies with Olink's Duolink product line. The companies will market the products jointly and each company will handle the sales for its own products, Olink said.